Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Zithromac Iv Special Investigation For Legionella Infection.

NCT01784770 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01784770
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01784770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Zithromac Iv Special Investigation For Legionella Infection.
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
March 27, 2013
Completion date
July 29, 2016
Enrollment
21 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

legionella pneumophila infections, legionnaires' disease